MASI
Masimo CorporationNASDAQHealthcare$178.59+0.33%ClosedMarket Cap: $9.59B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
13.27
P/S
6.28
EV/EBITDA
29.00
DCF Value
$28.67
FCF Yield
2.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.9%
Operating Margin
20.3%
Net Margin
-9.9%
ROE
-17.2%
ROA
-9.8%
ROIC
17.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $412.5M | 60.0% | $83.9M | $68.3M | $1.27 | — |
| FY 2025 | $1.53B | 61.9% | $312.8M | $-151.5M | $-2.80 | — |
| Q3 2025 | $371.5M | 62.1% | $83.6M | $-100.4M | $-1.84 | — |
| Q2 2025 | $370.9M | 62.9% | $64.5M | $51.3M | $0.94 | — |
| Q1 2025 | $372.0M | 62.9% | $78.0M | $-170.7M | $-3.17 | — |
| Q4 2024 | $600.7M | 40.7% | $-359.1M | $-349.6M | $-6.52 | — |
| FY 2024 | $2.09B | 48.0% | $-266.7M | $-304.9M | $-5.72 | — |
| Q3 2024 | $504.6M | 52.2% | $30.1M | $9.8M | $0.18 | — |
| Q2 2024 | $343.9M | 60.3% | $41.9M | $16.0M | $0.29 | — |
| Q1 2024 | $339.6M | 60.8% | $53.1M | $18.9M | $0.35 | — |
| Q4 2023 | $548.9M | 47.9% | $44.0M | $33.9M | $0.63 | — |
| FY 2023 | $2.05B | 49.0% | $136.5M | $81.5M | $1.51 | — |